Cargando…
COVID-19 and Liver Dysfunction
Introduction The pandemic of coronavirus disease 2019 (COVID-19) has caused over four million deaths, depleting resources and healthcare workers; therefore, in an attempt to stratify patients, the relationship between liver enzymes and clinical outcome was studied. This study aimed to assess the pat...
Autores principales: | Ibrahim, Nour, Hosri, Jad, Bteich, Yara, Dib, Alfred, Abou Rached, Antoine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8849487/ https://www.ncbi.nlm.nih.gov/pubmed/35186564 http://dx.doi.org/10.7759/cureus.21302 |
Ejemplares similares
-
Current landscape of clinical trials for HPV-positive head and neck squamous cell carcinoma (HNSCC)
por: Bteich, Yara T, et al.
Publicado: (2022) -
A Systematic Review of SARS-CoV-2-Associated Hepatic Dysfunction and the Impact on the Clinical Outcome of COVID-19
por: Radivojevic, Aleksandra, et al.
Publicado: (2022) -
Study of Liver Dysfunction in Hyperemesis Gravidarum
por: Gaba, Nayana, et al.
Publicado: (2020) -
Study of Endothelial Dysfunction in Patients With Non-alcoholic Fatty Liver Disease
por: Jose, Nijin, et al.
Publicado: (2021) -
Acute Liver Failure in a COVID-19 Patient Without any Preexisting Liver Disease
por: Gurala, Dhineshreddy, et al.
Publicado: (2020)